Richard M. Neve

Restriction of Receptor Movement Alters Cellular Response: Physical Force Sensing by EphA2

Joe W. Gray, Jay T. Groves, Khalid Salaita, 2010, Science.

Reproducible pharmacogenomic profiling of cancer cell line panels

Scott E. Martin, Richard Bourgon, Steve Lianoglou, 2016, Nature.

ZNF 217 , a candidate breast cancer oncogene amplified at 20 q 13 , regulates expression of the ErbB 3 receptor tyrosine kinase in breast cancer cells

Peggy J. Farnham, Seth Frietze, Colleen, 2014 .

ErbB2 Potentiates Breast Tumor Proliferation through Modulation of p27Kip1-Cdk2 Complex Formation: Receptor Overexpression Does Not Determine Growth Dependency

John M. Daly, R. Neve, H. Lane, 2000, Molecular and Cellular Biology.

ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells

Peggy J. Farnham, Seth Frietze, R. Neve, 2010, Oncogene.

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors

Jane Fridlyand, Antoni Ribas, Timothy R. Wilson, 2012, Nature.